Facebook
X
LinkedIn
Forward
APP Cancer Research Summit 2026
Overview
Join us for the APP Cancer Research Summit (ACRS), a two-day conference designed to empower advanced practice providers (APPs) with the practical knowledge and skills needed to succeed in oncology-focused clinical research. Whether you are curious, getting started, or already active in clinical research, ACRS is developed with experienced clinical research APPs to ensure the education meets the real-world needs of APPs across the oncology research continuum. Sessions will explore Clinical Trials 101, how to develop and lead your own research, how to advance your role on the research team, and emerging trends shaping oncology research. Held in conjunction with the Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer), ACRS offers a collaborative forum to learn, network, and grow within the clinical research community.
| Designation | Advance July 7, 2026 | Standard August 7, 2026 |
|---|---|---|
| MD, DO, PhD | $490 | $590 |
| Allied Health (NP, PA, RN, PharmD, Fellows, Residents, Retired) | $275 | $375 |
| Industry** | $790 | $890 |
** Defined as anyone employed by a drug, device, or diagnostic company. We allow Industry Professionals to register for our conferences unless you are employed in a sales role with your company. Please note that we will accept a limited number of Industry Professionals (excluding sales) to each conference.
Refunds of 50% of the registration fee will be provided if you cancel up to 30 days before the APP Cancer Research Summit (ACRS) commences. There are no refunds for cancellations within the 30-day window of the start of the event. To request a refund, please email [email protected].
Privacy Statement: For online registration, we take precautions to protect your information. When you submit sensitive information via the website, your information is protected both online and offline. In order to use this website, a user must first complete the registration form. During registration, a user is required to give certain information (such as name, email, mailing address, and payment information). This information is confidential and will only be used to contact you regarding your registration.
Please note: times are subject to change. Please check the syllabus for the most current version of the agenda upon arriving at the summit.
All Times Listed are for the Eastern Standard Time Zone
| Friday, August 7, 2026 | |
|---|---|
| 7:00am | Check-in and Breakfast in Exhibit Hall |
| 8:00am | Horizon CME App Overview |
| 8:10am | Welcome, Introductions, & CE Housekeeping |
| Block One: TBA | |
| 8:15am | (01) TBA » TBA |
| 9:15am | Break - Refreshments in the Exhibit Hall |
| Block Two: Foundations of Oncology Clinical Trials | |
| 9:40am | (02) Clinical Trials from Soup to Nuts » Bridget O'Brien, DNP, APRN, FNP-BC, AOCNP - Associate Professor, Director of FNP Program | Rush University | Oncology Nurse Practitioner | Northwestern Medicine | Chicago, IL |
| 10:05am | (03) Foundations of Oncology Clinical Trial Design » Erin Pierce, MSN, APRN, FNP-C - Associate Clinical Investigator | Nurse Practitioner | HonorHealth Research Institute | Scottsdale, AZ |
| 10:30am | (04) Evaluating the Quality of a Clinical Trial » Erin Pierce, MSN, APRN, FNP-C - Associate Clinical Investigator | Nurse Practitioner | HonorHealth Research Institute | Scottsdale, AZ |
| 10:50am | (05) Q+A Panel and Discussion: Block Two » Faculty from Sessions 02-04 |
| 11:00am | Gather for Lunch |
| 11:10am | Non-CME Symposium Lunch Sponsored by TBA » TBA |
| 11:55am | Dessert - Refreshments in Exhibit Hall |
| Block Three: Panel Discussion: The Clinical Research Team in Practice | |
| 12:10pm | (06) Panel Discussion: The Clinical Research Team in Practice » Kelsey P. Martin, AG-ACNP-BC, AOCNP - Nurse Practitioner | Sarah Cannon Research Institute | Nashville, TN » Diane Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN - Manager of Advanced Practice Providers | Department of Investigational Cancer Therapeutics | MD Anderson | Houston, TX » Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, FAPO - Nurse Practitioner/Associate Researcher/CCDR Lead | University of Hawaii Cancer Center/Hawaii M/U NCORP | Hawaii Pacific Health | Clinical Faculty, UH School of Nursing and Dental Hygiene | Honolulu, HI » Kelly Shanahan, MD - living with MBC since 2013 | President and Director of Research, METAvivor | Member, Patient Centered Dosing Initiative |
| 12:40pm | (07) APP Perspectives of Targeting KRAS » Erin Pierce, MSN, APRN, FNP-C - Associate Clinical Investigator | Nurse Practitioner | HonorHealth Research Institute | Scottsdale, AZ |
| 1:10pm | Message from the Cancer Charities |
| 1:25pm | Break - Trivia for Charity in the Exhibit Hall |
| Block Four: Participating in Clinical Trials: Practical Skills for APPs | |
| 1:45pm | (08) APP Responsibilities as a Sub-Investigator in Clinical Trials » Gayle Jameson, MSN, ACNP-BC, AOCN - Nurse Practitioner | Clinical Research Consultant | Associate Clinical Investigator |
| 2:15pm | (09) Grading and Documenting Adverse Events in Clinical Trials: "Side Effects May Include..." » Madeline Merrill, AGNP-BC, MSN - Clinical Trials Nurse Practitioner | Memorial Sloan Kettering Cancer Center | New York, NY |
| 2:45pm | (10) Building Investigator Excellence » Bridget O'Brien, DNP, APRN, FNP-BC, AOCNP - Associate Professor, Director of FNP Program | Rush University | Oncology Nurse Practitioner | Northwestern Medicine | Chicago, IL | Chair of the ECOG-ACRIN APP Committee |
| 3:15pm | (11) Q+A Panel and Discussion: Block Four » Faculty from Sessions 08 - 10 |
| 3:25pm | Break - Refreshments in the Exhibit Hall |
| Block Five: Expanding Access to Clinical Trials in Underserved Populations | |
| 3:50pm | (12) Patient Journey and Involvement in Clinical Trials » Kelly Shanahan, MD - President and Director of Research, METAvivor | Member, Patient Centered Dosing Initiative |
| 4:15pm | (13) Improving Diversity and Representation in Oncology Clinical Trials » Diane Barber, PhD, ANP-BC, AOCNP, FAANP, FAAN - Manager of Advanced Practice Providers | Department of Investigational Cancer Therapeutics | MD Anderson | Houston, TX |
| 4:40pm | (14) Expanding Clinical Trial Access in Rural Communities » Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, FAPO - Nurse Practitioner/Associate Researcher/CCDR Lead | University of Hawaii Cancer Center/Hawaii M/U NCORP | Hawaii Pacific Health | Clinical Faculty, UH School of Nursing and Dental Hygiene | Honolulu, HI |
| 5:00pm | (15) Q+A Panel and Discussion: Block Five » Faculty from Sessions 12-14 |
| 5:10pm | Networking Reception - Exhibit Hall |
| Saturday, August 8, 2026 | |
| 7:00am | Check-in |
| 7:55am | Horizon CME App Overview and CE Housekeeping |
| 8:00am | Welcome and Introductions |
| Block Six: Leading Clinical Research: Designing and Conducting Your Own Studies | |
| 8:05am | (16) Where to Begin: From Being a Sub-investigator to Clinical Trial Leadership » Gayle Jameson, MSN, ACNP-BC, AOCN - Nurse Practitioner | Clinical Research Consultant | Associate Clinical Investigator |
| 8:30am | Gather for Breakfast |
| 8:35am | Non-CME Breakfast Symposium Sponsored By TBA » TBA |
| 9:20am | Transition Break |
| 9:25am | (17) APP Involvement in Clinical Trial Design: Developing a Research Question and Protocol » Ke Yang, RN, BSN, MSN, DNP, PhD, AGNP, AOCNP - Nurse Practitioner, Precision Genomics Program | Hematology, Oncology | IU Health Simon Cancer Center | Indiana University Health | Indianapolis, Indiana |
| 9:50am | (18) Collaborating with a Biostatistician to Develop Your Own Oncology Clinical Trial » Bill Brady, PhD - Principal Biostatistician | Development Innovations | Sarah Cannon Research Institute | Nashville, TN |
| 10:15am | (19) From Numbers to Narrative: Mastering the Art of Interpreting and Presenting Clinical Research Data » Carol Peyton Bryant, DNP, RN, ACNP-BC - NP & PA Supervisor, Oncology & Hematology | Mayo Clinic | Phoenix, AZ |
| 10:35am | (20) Q+A Panel and Discussion: Block Six » Faculty from Sessions 16-19 |
| 10:45am | Break - Refreshments in the Exhibit Hall + Poster Session |
| Block 7: Clinical Trial Methodology (Shared Session With STOP Cancer) | |
| 11:50am | (21) Bringing Trials to Patients » TBA |
| 12:10pm | (22) Novel Endpoints for Therapeutic Response in Early Phase Trials » TBA |
| 12:30pm | (23) Statistical Trial Design for Early Phase Clinical Trials » TBA |
| 12:50pm | (24) Role of Advocacy in Drug Development » TBA |
| 1:10pm | (25) Q+A Panel and Discussion: Block Seven » Faculty from Sessions 21-24 |
| 1:30pm | Gather for Lunch |
| 1:35pm | Buffet Lunch / Non-CME/CE Presentation Sponsored by TBA » TBA |
| 2:20pm | Dessert Break in the Exhibit Hall |
| Block Eight: Bringing Bispecific Antibody and CAR T-cell Therapy into the Community Setting | |
| 2:35pm | (26) Lymphoma: Update on Bispecific Antibody Therapy and CAR T-cell Therapy and Ongoing Clinical Trials » Laura J. Zitella, MS, RN, ACNP-BC, AOCN - Associate Clinical Professor, Hematology Nurse Practitioner | University of California, San Francisco | San Francisco, CA |
| 3:15pm | Break - Refreshments in the Exhibit Hall |
| 3:35pm | (27) Solid Tumors: Update on Bispecific Antibody Therapy and Ongoing Clinical Trials » Laura J. Zitella, MS, RN, ACNP-BC, AOCN - Associate Clinical Professor, Hematology Nurse Practitioner | University of California, San Francisco | San Francisco, CA |
| 4:00pm | (28) Clinical Trial Experience: Operationalizing Bispecific Antibody Therapy in the Community Setting » TBA |
| 4:30pm | (29) Q+A Panel and Discussion: Block Eight » Faculty from Sessions 26-28 |
| 4:35pm | Closing Comments |
We want to ensure that your time at the APP Cancer Research Summit 2026 conference is convenient and memorable. Staying at our host hotel provides a hassle-free experience and puts you at the heart of the activity surrounding the conference.
Overnight Accommodations:
Dates for discounted rates: August 6-8, 2026
Discounted Booking Deadline: July 4, 2026
Click here to book your room today!
Room rate: $359
Parking: Complimentary parking
Disclaimer
All reservations must be booked using the link above before the closing date listed. Overnight accommodation, parking, and resort fees will revert back to standard hotel pricing outside of the dates above. A set number of rooms have been blocked off for the discounted pricing. If all of those rooms have already been booked, discounted pricing may not be available for additional rooms or accommodations.
Available Credit
- 11.75 ACPE Pharmacy
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This conference is approved for up to 11.75 credit by the Washington State Pharmacy Association.
This activity is approved for up to 11.75 credit by the Washington State Pharmacy Association. Activity Type: Live| Start/End date: Fri, 08/07/2026 - 4:00am-Sat, 08/08/2026 - 1:45pm The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity - please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile. If you encounter any CPE problems, please contact WSPA at 425- 228-7171 - 11.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this Live activity for a maximum of 11.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 11.75 ANCC
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 11.75 credit.
- 1.50 Pharmacology
This nursing continuing professional development activity was approved by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.Upon completion, NPs and RNs will be awarded up to 1.50 credit.